# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA633056 | A | The half-life period for the release of paclitaxel after cyclization was determined for the compound | 4 | ALA1135012 | assay format | Scientific Literature | ||
2. | ALA707931 | F | Compound along with dithiothreitol (DTT) was evaluated for its cytotoxicity against L2987 lung carcinoma cells | Homo sapiens | 4 | ALA1135012 | cell-based format | Scientific Literature | |
3. | ALA879949 | F | Compound was evaluated for its cytotoxicity against L2987 lung carcinoma cells | Homo sapiens | 5 | ALA1135012 | cell-based format | Scientific Literature | |
4. | ALA847151 | F | Dose required for the compound to elicit the Antitumor activity: No effective activity | 3 | ALA1135012 | assay format | Scientific Literature | ||
5. | ALA926197 | A | Half life in DTT buffer assessed as taxol release | 4 | ALA1140624 | assay format | Scientific Literature | ||
6. | ALA926198 | F | Cytotoxicity against human L2987 cells | Homo sapiens | 5 | ALA1140624 | cell-based format | Scientific Literature | |
7. | ALA926199 | F | Cytotoxicity against human L2987 cells in presence of DTT | Homo sapiens | 4 | ALA1140624 | cell-based format | Scientific Literature |